Published Studies Related to Zovirax Topical (Acyclovir Topical)
Well-designed clinical trials related to Zovirax Topical (Acyclovir Topical)
Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. [2009.03]
Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial. [2008]
A random clinical trial study to assess the efficiency of topical applications of podophyllin resin (25%) versus podophyllin resin (25%) together with acyclovir cream (5%) in the treatment of oral hairy leukoplakia. [2007.01]
Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial. [2006.08.15]
Role of acyclovir gel in herpes simplex: clinical implications. [2003.07]
High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. [2003.03]
Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. [2002.06]
A comparison of topical application of penciclovir 1% cream with acyclovir 3% cream for treatment of genital herpes: a randomized, double-blind, multicentre trial. [2000.09]
A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. [1999.06]
Cidofovir use in acyclovir-resistant herpes infection. [1997.12]
Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study. [1996.02]
Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. [1994.12]
Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus. [1994]
Acyclovir ointment plus topical betamethasone or placebo in first episode disciform keratitis. [1992.12]
[A topical solution of 40% idoxuridine in dimethyl sulfoxide compared to oral acyclovir in the treatment of herpes zoster. A double-blind multicenter clinical trial] [1992.02.22]
Double-masked trial of topical acyclovir and steroids in the treatment of herpes zoster ocular inflammation. [1991.09]
The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. [1991.04]
A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis. [1990.05]
Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind randomized trial. [1989.06]
Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences. [1989.05]
Well-designed clinical trials possibly related to Zovirax Topical (Acyclovir Topical)
Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial. [2011.04]
[Comparison on therapeutic effect between surround needling plus thin cotton moxibustion and Western medicine for herpes zoster]. [2011.03]
A new topical treatment protocol for oral hairy leukoplakia. [2010.11]
Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: A randomized, double-blind, placebo-controlled, patient-initiated clinical trial. [2010.09.17]
Viremia in acute herpes zoster. [2009.07.01]
Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial. [2002.06]
Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. [2002.03]
Combined herbal preparation for topical treatment of Herpes labialis. [2001.12]
A pilot study of treatment of herpes labialis with 1072 nm narrow waveband light. [2001.03]
Pharmacotherapy for Behcet's syndrome. [2000]
Local therapy for cytomegalovirus retinitis. [1998.02]
Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis. [1997.07]
Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. [1997.05.07]
Evaluation of topical 0.03% flurbiprofen drops in the treatment of herpetic stromal keratitis. [1996.05]
Treatments for postherpetic neuralgia--a systematic review of randomized controlled trials. [1996.02]
[Clinical comparison of two topical antiviral ointments in herpes] [1995.02.19]
Epidermal growth factor in the topical treatment of herpetic corneal ulcers. [1994]
Efficacy of tromantadine and aciclovir in the topical treatment of recurrent herpes orofacialis. Comparison in a clinical trial. [1993.04]
Design and organization of the herpetic eye disease study (HEDS). [1991]
Other research related to Zovirax Topical (Acyclovir Topical)
Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir. [2011.04]
The role of topical 5% acyclovir and 1% hydrocortisone cream (Xeresetrade mark) in the treatment of recurrent herpes simplex labialis. [2010.09]
Controlled release polymeric ocular delivery of acyclovir. [2010.07]
Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner. [2010.03]
Evaluation of safety and efficacy of prolonged suppressive therapy of genital herpes with valacyclovir. [2009.07]
In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations. [2009.03]
Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections. [2009]
Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis. [2008.11]
Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. [2008.07.09]
Randomized clinical study comparing Compeed(R) cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis. [2008.05.06]
Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty. [2008.02]
Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid. [2007.04]
Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation. [2007.01]
Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient. [2006.09]
Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial. [2006]
Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides. [2005.06]
In vitro percutaneous penetration of acyclovir from solvent systems and Carbopol 971-P hydrogels: influence of propylene glycol. [2005.05]
Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits. [2004.04]
Topical delivery of different acyclovir palmitate liposome formulations through rat skin in vitro. [2004.03]
In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model. [2003.06]
Management of acyclovir-resistant herpes simplex virus. [2003.04]
Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice. [2003.03.06]
Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. [2003.01.13]
Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: a population-based observational study. [2003]
Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir. [2002.10.15]
Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection. [2001.09]
Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers. [2001.07.10]
Healing of recurrent herpes simplex corneal epithelial lesions treated with topical acyclovir A non-contact photomicrographic in vivo study in the human cornea. [2001.06]
Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir). [2001.01]
[An experimental study of a new route for Acyclovir administration for anti-keratitis therapeutic treatment] [2000.12]
Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations. [2000.09]
Oral acyclovir for the management of herpes simplex virus keratitis in children. [2000.02]
Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. [2000.01.03]
Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs. [2000.01]
Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection. [2000.01]
Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study. [1999.08.01]
Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice. [1999.05]
Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis. [1999.03]
Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model. [1999.02]
Assessment of correlation between skin target site free drug concentration and the in vivo topical antiviral efficacy in hairless mice for (E)-5-(2-bromovinyl)-2'-deoxyuridine and acyclovir formulations. [1998.08]
Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo. [1998.07]
Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus. [1998.03]
The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo. [1998.02]
Acyclovir cream prevents clinical and thermographic progression of recrudescent herpes labialis beyond the prodromal stage. [1998.01]
Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis. [1998]
Bioadhesive microspheres for ophthalmic administration of acyclovir. [1997.08]
Relationship of skin target site free drug concentration (C*) to the in vivo efficacy: an extensive evaluation of the predictive value of the C* concept using acyclovir as a model drug. [1997.07]
The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. [1997.04.28]
Intravenous acyclovir treatment for extensive herpetic keratitis in a liver transplant patient. [1997]
Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis. [1997]
Treatment of herpetic keratitis with acyclovir: benefits and problems. [1997]
Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice. [1996.12]
Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates. [1996.08]
Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group. [1996.06.01]
[Treatment of herpes simplex keratouveitis with systemic and local administration of acyclovir] [1996.04]
Correlation of in vivo topical efficacies with in vitro predictions using acyclovir formulations in the treatment of cutaneous HSV-1 infections in hairless mice: an evaluation of the predictive value of the C* concept. [1996.03]
Testing of the in vivo therapeutic efficacy on the cutaneous herpes simplex infections of the autochthonous product 5% Acyclovir ointment. [1996.01]
Thermographic resolution of the prodromal phase of herpes labialis treated with acyclovir. [1995.08]
Treatment of acyclovir-unresponsive cutaneous herpes simplex virus infection with topically applied SP-303. [1994.12]
Estimation of skin target site acyclovir concentrations following controlled (trans)dermal drug delivery in topical and systemic treatment of cutaneous HSV-1 infections in hairless mice. [1994.07]
Solar simulator-induced herpes simplex labialis: use in evaluating treatment with acyclovir plus 348U87. [1994.04]
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). [1994.04]
|
